Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Meike von Wulffen, Veronika Luehrmann, Stefanie Robeck, Antonella Russo, Lena Fischer-Riepe, Martijn van den Bosch, Peter van Lent, Karin Loser, Dmitry I. Gabrilovich, Sven Hermann, Johannes Roth & Thomas Vogl. (2023) S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Reports 42:8, pages 113006.
Crossref
Crossref
T. V. Tyrinova, A. Yu. Morenkova, A. V. Fedorova, M. A. Tikhonova, N. A. Ilina, O. A. Chumasova & A. E. Sizikov. (2023) Myeloid-derived suppressor cells as biomarkers of the effectiveness of therapy with new biological agents in axial spondyloarthritis. Medical Immunology (Russia) 25:5, pages 1079-1084.
Crossref
Crossref
Xin Xiong, Mengjia Yu, Dinghang Wang, Yange Wang & Longxian Cheng. (2023) Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis. Immunity, Inflammation and Disease 11:6.
Crossref
Crossref
Dandan Xu, Cheng Li, Yushan Xu, Mingyue Huang, Dawei Cui & Jue Xie. (2022) Myeloid-derived suppressor cell: A crucial player in autoimmune diseases. Frontiers in Immunology 13.
Crossref
Crossref
Liangjie Xu, Cuicui Zhou, Yi Liang, Tinpan Fan, Fen Zhang, Xinxin Chen & Wei Yuan. (2022) Epigenetic modifications in the accumulation and function of myeloid-derived suppressor cells. Frontiers in Immunology 13.
Crossref
Crossref
Ernest Osei, Christabel Oghinan, Akua Asare, Hillary Ho & Solomon Manful. (2021) Review of clinical and emerging biomarkers for early diagnosis and treatment management of pancreatic cancer: towards personalised medicine. Journal of Radiotherapy in Practice 21:3, pages 421-433.
Crossref
Crossref
Mohammad A. Al-Mterin & Eyad Elkord. (2022) Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets. Exploration of Targeted Anti-tumor Therapy, pages 497-510.
Crossref
Crossref
Malihe Azadehrah, Shohre Vosoogh & Mahboobeh Azadehrah. (2022) The roles and therapeutic applications of cytokines in endometrial cancer. Journal of Reproductive Immunology 152, pages 103652.
Crossref
Crossref
Yan Wang, Chong Yan, Caixia Su, Ying Wang, Sushan Luo, Jun Lu, Chongbo Zhao, Gan Zhao & Jianying Xi. (2022) Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy. Frontiers in Neurology 13.
Crossref
Crossref
Alhasan Alsalman, Mohammad A. Al-Mterin & Eyad Elkord. (2022) Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19. Journal of Immunology Research 2022, pages 1-13.
Crossref
Crossref
Brian S. M. Munansangu, Colin Kenyon, Gerhard Walzl, André G. Loxton, Leigh A. Kotze & Nelita du Plessis. (2022) Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology. International Journal of Molecular Sciences 23:7, pages 3512.
Crossref
Crossref
Jing Wang, Mei Gong, Xirong Fan, Dalu Huang, Jinshu Zhang & Cheng Huang. (2021) Autophagy-related signaling pathways in non-small cell lung cancer. Molecular and Cellular Biochemistry 477:2, pages 385-393.
Crossref
Crossref
Jie Yang & Liman Zhang. (2022) The roles and therapeutic approaches of MSC-derived exosomes in colorectal cancer. Clinical and Translational Oncology 24:6, pages 959-967.
Crossref
Crossref
Seyed Hossein Aghamiri, Khalil Komlakh & Mehran Ghaffari. (2022) Toll-Like Receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy. International Immunopharmacology 102, pages 108398.
Crossref
Crossref
Faria Jafarzadeh, Amin Javanbakht, Niloofar bakhtar, Alaleh Dalvand, Mahya Shabani & Mohammad-Mehdi Mehrabinejad. (2021) Association between diabetic retinopathy and polymorphisms of cytokine genes: a systematic review and meta-analysis. International Ophthalmology 42:1, pages 349-361.
Crossref
Crossref
Zijian Wang, Chunyang Zhou & Shengjie Yang. (2021) The roles, controversies, and combination therapies of autophagy in lung cancer. Cell Biology International 46:1, pages 3-11.
Crossref
Crossref
O. Yu Leplina, M. A Tikhonova, T. V Tyrinova, I. V Meledina, O. I Zheltova, A. A Ostanin & E. R Chernykh. (2021) The relationship between myeloid-derived supressor cells and clinico-laboratory parameters in patients with liver cyrrosis. Genes & Cells 16:4, pages 55-62.
Crossref
Crossref
Lixia Zhang, Cameron L. Kirkwood, Jiho Sohn, Ashley Lau, Mary Bayers-Thering, Supinder Kour Bali, Sridhar Rachala, John M. Marzo, Mark J. Anders, Frank Beier & Keith L. Kirkwood. (2021) Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodeling. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Krishnapriya M. Varier, Hemavathi Dhandapani, Wuling Liu, Jialei Song, Chunlin Wang, Anling Hu, Yaacov Ben-David, Xiangchun Shen, Yanmei Li & Babu Gajendran. (2021) An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Mohammad Salemizadeh Parizi, Fatemeh Salemizadeh Parizi, Saeed Abdolhosseini, Shohreh Vanaei, Ali Manzouri & Farnoosh Ebrahimzadeh. (2021) Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategies. Inflammopharmacology 29:6, pages 1613-1624.
Crossref
Crossref
Rubia Isler Mancuso, Juliana Hofstätter Azambuja & Sara Teresinha Olalla Saad. (2021) Artesunate strongly modulates myeloid and regulatory T cells to prevent LPS-induced systemic inflammation. Biomedicine & Pharmacotherapy 143, pages 112211.
Crossref
Crossref
Bryan Latrell Holloman, Mitzi Nagarkatti & Prakash Nagarkatti. (2021) Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases. International Journal of Molecular Sciences 22:14, pages 7302.
Crossref
Crossref
A. Yu. Morenkova, M. A. Tikhonova, T. V. Tyrinova, E. V. Batorov, A. E. Sizikov, O. A. Chumasova, A. E. Sulutian, A. A. Ostanin & E. R. Chernykh. (2021) Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis. Medical Immunology (Russia) 23:2, pages 327-338.
Crossref
Crossref
Jilu Zhang, Alan Hodges, Shu-Hsia Chen & Ping-Ying Pan. (2021) Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases. Cellular Immunology 362, pages 104300.
Crossref
Crossref
Jamshid Gholizadeh Navashenaq, Arezoo Gowhari Shabgah, Mahdiyeh Hedayati-Moghadam, Nazila Ariaee, Hamed Mohammadi, Maryam Hemmatzadeh, Sara Azhdari, Tannaz Jamialahmadi, Thozhukat Sathyapalan & Amirhossein Sahebkar. (2021) The role of myeloid-derived suppressor cells in rheumatoid arthritis: An update. Life Sciences 269, pages 119083.
Crossref
Crossref
Lan Yan, Mingge Liang, Tong Yang, Jinyu Ji, Goutham Sanker Jose Kumar Sreena, Xiaoqiang Hou, Meiqun Cao & Zhitao Feng. (2020) The Immunoregulatory Role of Myeloid-Derived Suppressor Cells in the Pathogenesis of Rheumatoid Arthritis. Frontiers in Immunology 11.
Crossref
Crossref
Misagh Rajabinejad, Gelayol Asadi, Sedigheh Ranjbar, Leila Afshar Hezarkhani, Farhad Salari, Ali Gorgin Karaji & Alireza Rezaiemanesh. (2020) Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer. Gene 746, pages 144637.
Crossref
Crossref